DK0708104T3 - Fremgangsmåde og mellemprodukt til fremstilling af terazosinhydrochloriddihydrat - Google Patents
Fremgangsmåde og mellemprodukt til fremstilling af terazosinhydrochloriddihydratInfo
- Publication number
- DK0708104T3 DK0708104T3 DK95103188.9T DK95103188T DK0708104T3 DK 0708104 T3 DK0708104 T3 DK 0708104T3 DK 95103188 T DK95103188 T DK 95103188T DK 0708104 T3 DK0708104 T3 DK 0708104T3
- Authority
- DK
- Denmark
- Prior art keywords
- tetrahydrofuroyl
- dimethoxy
- amino
- preparation
- hydrochloride dihydrate
- Prior art date
Links
- KKCIOUWDFWQUBT-UHFFFAOYSA-N thyronine Chemical compound C1=CC(CC(N)C(O)=O)=CC=C1OC1=CC=C(O)C=C1 KKCIOUWDFWQUBT-UHFFFAOYSA-N 0.000 title abstract 2
- IWSWDOUXSCRCKW-UHFFFAOYSA-N [6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-yl]azanium;chloride Chemical compound Cl.N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1CCCO1 IWSWDOUXSCRCKW-UHFFFAOYSA-N 0.000 abstract 2
- UKESBLFBQANJHH-UHFFFAOYSA-N 1-(Tetrahydro-2-furoyl)piperazine Chemical compound C1CNCCN1C(=O)C1CCCO1 UKESBLFBQANJHH-UHFFFAOYSA-N 0.000 abstract 1
- HWIIAAVGRHKSOJ-UHFFFAOYSA-N 2-chloro-6,7-dimethoxyquinazolin-4-amine Chemical compound ClC1=NC(N)=C2C=C(OC)C(OC)=CC2=N1 HWIIAAVGRHKSOJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003495 polar organic solvent Substances 0.000 abstract 1
- 239000002516 radical scavenger Substances 0.000 abstract 1
- NZMOFYDMGFQZLS-UHFFFAOYSA-N terazosin hydrochloride dihydrate Chemical compound [H+].O.O.[Cl-].N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1CCCO1 NZMOFYDMGFQZLS-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/324,635 US5504207A (en) | 1994-10-18 | 1994-10-18 | Process and intermediate for the preparation of terazosin hydrochloride dihydrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0708104T3 true DK0708104T3 (da) | 1997-03-10 |
Family
ID=23264439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95103188.9T DK0708104T3 (da) | 1994-10-18 | 1995-03-06 | Fremgangsmåde og mellemprodukt til fremstilling af terazosinhydrochloriddihydrat |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5504207A (pt) |
| EP (1) | EP0708104B1 (pt) |
| JP (1) | JP2711230B2 (pt) |
| AT (1) | ATE143959T1 (pt) |
| BR (1) | BR1100705A (pt) |
| CA (1) | CA2143971C (pt) |
| DE (1) | DE69500064T2 (pt) |
| DK (1) | DK0708104T3 (pt) |
| ES (1) | ES2089993T3 (pt) |
| GR (2) | GR960300047T1 (pt) |
| HK (1) | HK130297A (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5587377A (en) * | 1995-10-24 | 1996-12-24 | Invamed, Inc. | Terazosin crystalline polymorph and pharmaceutical compositions thereof |
| DE19546573A1 (de) * | 1995-12-13 | 1997-06-19 | Uetikon Chemie Gmbh | Kristallines Polymorph von Terazosin-Hydrochlorid, sowie Verfahren zu seiner Herstellung |
| US5952003A (en) * | 1996-08-01 | 1999-09-14 | Novartis Corporation | Terazosin capsules |
| DK0849266T3 (da) * | 1996-12-20 | 2007-06-04 | Heumann Pcs Gmbh | Hidtil ukendt polymorf form af doxazosin-mesylat (form III) |
| EP0849265A1 (de) * | 1996-12-20 | 1998-06-24 | HEUMANN PHARMA GmbH | Neue polymorphe Form von Doxazosin-Mesylat (Form II) |
| EP0849264A1 (de) * | 1996-12-20 | 1998-06-24 | HEUMANN PHARMA GmbH | Neue polymorphe Form von doxazosinmesylat (Form I) |
| US6248888B1 (en) * | 1997-11-14 | 2001-06-19 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of terazosin hydrochloride dihydrate |
| US6200573B1 (en) | 1999-12-03 | 2001-03-13 | Starcor Pharmaceuticals, Inc. | Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia |
| US20070161791A1 (en) * | 2006-01-09 | 2007-07-12 | Narsimha Reddy Penthala | Process for the preparation of terazosin hydrocloride dihydrate |
| CN101547696A (zh) * | 2006-08-08 | 2009-09-30 | 奥斯拜客斯制药有限公司 | 具有α肾上腺素能阻断效应的取代喹唑啉化合物的制备和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4026894A (en) * | 1975-10-14 | 1977-05-31 | Abbott Laboratories | Antihypertensive agents |
| GB1591490A (en) * | 1977-08-04 | 1981-06-24 | Abbott Lab | 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate |
| EP0237608B1 (de) * | 1986-03-21 | 1992-01-29 | HEUMANN PHARMA GMBH & CO | Kristalline, wasserfreie Sigma -Form von 2-[4-(2-Furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxychinazolinhydrochlorid und Verfahren zu ihrer Herstellung |
| US5212176A (en) * | 1990-06-29 | 1993-05-18 | Abbott Laboratories | R(+)-terazosin |
| CA2071915A1 (en) * | 1990-08-23 | 1992-02-24 | Tadao Shoji | Antiviral agent |
| JP2652272B2 (ja) * | 1990-12-31 | 1997-09-10 | 住化ファインケム株式会社 | １−（４−アミノ−６，７−ジメトキシ−２−キナゾリニル）−４−（２−テトラヒドロフロイル）ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法 |
| US5294615A (en) * | 1993-04-29 | 1994-03-15 | Abbott Laboratories | Terazosin polymorph and pharmaceutical composition |
-
1994
- 1994-10-18 US US08/324,635 patent/US5504207A/en not_active Expired - Fee Related
-
1995
- 1995-03-06 EP EP95103188A patent/EP0708104B1/en not_active Revoked
- 1995-03-06 CA CA002143971A patent/CA2143971C/en not_active Expired - Fee Related
- 1995-03-06 ES ES95103188T patent/ES2089993T3/es not_active Expired - Lifetime
- 1995-03-06 AT AT95103188T patent/ATE143959T1/de not_active IP Right Cessation
- 1995-03-06 DK DK95103188.9T patent/DK0708104T3/da active
- 1995-03-06 DE DE69500064T patent/DE69500064T2/de not_active Revoked
- 1995-03-16 JP JP7057435A patent/JP2711230B2/ja not_active Expired - Fee Related
-
1996
- 1996-08-31 GR GR960300047T patent/GR960300047T1/el unknown
- 1996-10-10 GR GR960402604T patent/GR3021319T3/el unknown
-
1997
- 1997-05-08 BR BR1100705-2A patent/BR1100705A/pt active Search and Examination
- 1997-06-26 HK HK130297A patent/HK130297A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0708104A1 (en) | 1996-04-24 |
| ES2089993T1 (es) | 1996-10-16 |
| EP0708104B1 (en) | 1996-10-09 |
| JPH08134066A (ja) | 1996-05-28 |
| ATE143959T1 (de) | 1996-10-15 |
| DE69500064D1 (de) | 1996-11-14 |
| CA2143971A1 (en) | 1996-04-19 |
| HK130297A (en) | 1997-09-19 |
| GR960300047T1 (en) | 1996-08-31 |
| JP2711230B2 (ja) | 1998-02-10 |
| GR3021319T3 (en) | 1997-01-31 |
| DE69500064T2 (de) | 1997-04-10 |
| ES2089993T3 (es) | 1997-02-16 |
| US5504207A (en) | 1996-04-02 |
| CA2143971C (en) | 1997-06-03 |
| BR1100705A (pt) | 1999-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0708104T3 (da) | Fremgangsmåde og mellemprodukt til fremstilling af terazosinhydrochloriddihydrat | |
| EA199900953A1 (ru) | ЗАМЕЩЕННЫЕ ПИРАЗОЛЫ, КАК ИНГИБИТОРЫ p38 КИНАЗЫ | |
| NO20005641D0 (no) | En fremgangsmåte og en anordning i et trådlöst kommunikasjonssystem | |
| CY1112916T1 (el) | 3-ζ-1-(4-(ν-((4-μεθυλ-πιπεραζιν-1-υλ)-μεθυλκαρβονυλ)-ν-μεθυλ-αμινο)-ανιλινο)-1-φαινυλ-μεθυλενο-6-μεθοξυκαρβονυλ-2-ινδολινονη-μονοαιθανοσουλφονικη και η χρηση αυτης ως φαρμακευτικη συνθεση | |
| DK1131318T3 (da) | Fremgangsmåde til fremstilling af 5-substituerede pyrazoler under anvendelse af dithietaner | |
| ATE411980T1 (de) | (2s,4s)-4-fluor-1-ä4-fluor-beta-(4-fluorphenyl) l-phenylalanylü-2-pyrrolidincarbonitril-p- toluolsulfonsäuresalz und wasserfreie kristalline formen davon | |
| NO20053513D0 (no) | Fremgangsmate for fremstilling av en pressfilt, og en pressfilt, med formen av en lukket sloyfe | |
| DK1539966T3 (da) | Fremgangsmåde til fremstilling af proteiner | |
| ATE291024T1 (de) | Neue 4-aminofuropyrimidine und ihre verwendung | |
| DE60005698D1 (de) | In-situ herstellung von polyasparaginestermischungen | |
| ATE440078T1 (de) | Verfahren zur herstellung von alkylaminen | |
| BRPI0409580A (pt) | compostos de quinazolina | |
| ATE440088T1 (de) | Verfahren zur herstellung von 4-(3'-chlor-4'- fluoranilino)-7-methoxy-6-(3- morpholinopropoxy)chinazolin | |
| ATE337607T1 (de) | Chipkondensator und verfahren zu dessen herstellung | |
| ATE445661T1 (de) | Polymer enthaltend substituierte triphenylamin- einheiten | |
| ATE253550T1 (de) | In-situ herstellung einer polyasparaginsäureestermischung | |
| FI20012199A (fi) | Menetelmä signaalin tahdistumisen suorittamiseksi langattomassa päätelaitteessa ja langaton päätelaite | |
| MXPA02001406A (es) | Heterociclilos-2h-cromenos substituidos. | |
| IS1650B (is) | Aðferð til framleiðslu á 2-{4-[4-(4-klóró-1-pýrazólýl)-bútýl]-1-píperazinýl}pýrimídín (Lesipitron) | |
| DK1252159T3 (da) | Fremgangsmåde til fremstilling af heterocycliske forbindelser | |
| DK1620404T3 (da) | Hidtil ukendt fremgangsmåde til fremstilling af 2-aminomethylpyridinderivater | |
| IL153144A0 (en) | Method for preparing substituted 5-amino-n-phenyl-1,2,4-triazole-3-sulfonamides | |
| DK1392652T3 (da) | Fremgangsmåde til fremstilling af 1,3-disubstituerede 2-nitroguanidiner | |
| DE60032998D1 (de) | Freigabeverfahren für die erste Bereitstellung eines Endgerätes | |
| ATE349427T1 (de) | Tryptaseinhibitoren |